Physician

Sam Mazj, MD

According to 2025 Medicare claims, Sam Mazj, MD (NPI: 1043287378) practices hematology/oncology in the Chico, CA market, with the plurality of this provider's patient population coming from Butte, CA. This provider's primary affiliated billing organization is ENLOE SPECIALTY PHYSICIANS, INC (NPI: 1306105721; TIN: 383873665) and primary practice location at 95926-2273. Mazj is affiliated with the Caravan Health ACO 50 LLC (ACO ID: A5160) and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Mazj's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 865 traditional Medicare patients, billed 4,596 HCPCS/CPT codes, and received $356,061 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,429 prescription claims across 319 beneficiaries totaling $7,398,543 in drug costs, led by Jakafi (Ruxolitinib Phosphate). DME data shows 72 claims. Open Payments data shows 33 records totaling $25,632. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,676,604 to $7,398,543. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $19,310 to $7,425.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	507	1,511	$86,009
2016	494	1,442	$88,683
2017	527	1,546	$90,225
2018	469	1,240	$70,875
2019	536	98,675	$1,903,895
2020	641	241,540	$3,637,718
2021	661	271,174	$4,807,061
2022	676	165,645	$3,493,534
2023	802	3,388	$306,861
2024	865	4,596	$356,061

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	166	1,131	$1,676,604
2016	183	1,318	$2,513,251
2017	178	1,316	$3,304,434
2018	159	1,169	$3,343,496
2019	174	1,033	$2,747,305
2020	183	1,128	$3,485,707
2021	179	1,192	$4,054,543
2022	240	1,388	$5,559,690
2023	314	2,164	$6,092,950
2024	319	2,429	$7,398,543

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	23	511	$88,960
2016	24	288	$65,293
2017	N/R	54	$11,531
2018	N/R	94	$11,922
2019	25	178	$16,282
2020	41	200	$18,010
2021	29	130	$11,227
2022	44	146	$5,350
2023	24	100	$16,594
2024	N/R	72	$2,046

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	636	2,409	$108
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	501	938	$68
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	59	71	$45
G2212	Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or	87	138	$24
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	378	884	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jakafi	Ruxolitinib Phosphate	70	2,100	$1,180,543
Revlimid	Lenalidomide	44	1,225	$887,529
Lenalidomide	Lenalidomide	41	1,141	$718,371
Tagrisso	Osimertinib Mesylate	27	810	$454,015
Brukinsa	Zanubrutinib	38	1,134	$407,661

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	34	$1,400
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	24	$433
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	14	$213

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	33	$25,632	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Sam Mazj, MD?

Tedicare shows public-source Medicare data for Sam Mazj, MD (NPI 1043287378), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sam Mazj, MD have ACO affiliation data?

Sam Mazj, MD is shown with ACO affiliation data for Caravan Health ACO 50 LLC (MSSP, ACO ID A5160) and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Sam Mazj, MD?

Sam Mazj, MD is linked to ENLOE SPECIALTY PHYSICIANS, INC (billing NPI 1306105721) in the available physician profile data.

Does Sam Mazj, MD have Open Payments data?

Sam Mazj, MD has 33 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.